NAICS category

In-Vitro Diagnostic Substance Manufacturing

NAICS 325413

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

Part of Manufacturing →

$179.8M
Federal awards
FY2026 · data still posting
4
Recipients
NAICS 325413
Code

NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) accounted for $179.8M in federal contracts in FY2026, led by the Department of Veterans Affairs, across 4 recipients. FY2026 ended Sep 30 and its data is still posting. Computed

Obligations by year

Computed
$923.9M
FY20
$2.1B
FY21
$5.2B
FY22
$2B
FY23
$149.2M
FY24
$170.5M
FY25
$179.8M
FY26 partial
▼ 82%
FY20 to FY25

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • In-Vitro Diagnostic Substance Manufacturing (NAICS 325413) accounted for $179.8M in federal obligations in FY2026, compared with $170.5M in FY2025.
  • The Department of Veterans Affairs provided 61% of it.

Top recipients

Computed

Recipient breakdown available for less than 1% of obligations shown

Awards

Source

Largest FY2026 awards in this category

Awards coded NAICS 325413 that started in FY2026, by the amount obligated on each so far.

No award on record in this category started in FY2026.

Largest awards in this category

awarded 2022$1.8B
awarded 2022$569.5M
awarded 2021$357M
awarded 2022$205.2M

Total value over each award’s life, largest first.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.